The Cochrane Library: Cochrane Database of Systematic Reviews

DOI: 10.1002/14651858

Reviews/Protocols listed by Cochrane Review Group


  1. Cochrane Acute Respiratory Infections Group
  2. Cochrane Airways Group
  3. Cochrane Anaesthesia, Critical and Emergency Care Group
  4. Cochrane Back and Neck Group
  5. Cochrane Bone, Joint and Muscle Trauma Group
  6. Cochrane Breast Cancer Group
  7. Cochrane Childhood Cancer Group
    1. About this group
    2. Reviews
      1. 123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastomaReviewDiagnostic
      2. Antibiotic and other lock treatments for tunnelled central venous catheter-related infections in children with cancerReview
      3. Antibody therapies for lymphoma in childrenReview
      4. Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in childhoodReview
      5. Chemotherapy for children with medulloblastomaReview
      6. Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patientsReview
      7. Different infusion durations for preventing platinum-induced hearing loss in children with cancerReview
      8. Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancerReview
      9. Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patientsReview
      10. Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patientsReview
      11. Hepatic late adverse effects after antineoplastic treatment for childhood cancerReview
      12. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastomaReview
      13. High-dose chemotherapy for children and young adults with stage IV rhabdomyosarcomaReview
      14. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemiaReview
      15. Influenza vaccination in children being treated with chemotherapy for cancerReview
      16. Interventions for promoting participation in shared decision-making for children with cancerReview
      17. Interventions other than anticoagulants and systemic antibiotics for prevention of central venous catheter-related infections in children with cancerReview
      18. Intracystic bleomycin for cystic craniopharyngiomas in childrenReview
      19. Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropeniaReview
      20. Medical interventions for the prevention of platinum-induced hearing loss in children with cancerReview
      21. Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancerReview
      22. Methotrexate for high-grade osteosarcoma in children and young adultsReview
      23. Minimally invasive surgery versus open surgery for the treatment of solid abdominal and thoracic neoplasms in childrenReview
      24. Nutritional interventions for survivors of childhood cancerReview
      25. Nutritional support in children and young people with cancer undergoing chemotherapyReview
      26. Physical exercise training interventions for children and young adults during and after treatment for childhood cancerReview
      27. Platinum-induced hearing loss after treatment for childhood cancerReview
      28. Radiotherapy for diffuse brainstem glioma in children and young adultsReview
      29. Rapid COJEC versus standard induction therapies for high-risk neuroblastomaReview
      30. Retinoic acid post consolidation therapy for high-risk neuroblastoma patients treated with autologous hematopoietic stem cell transplantationReview
      31. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous cathetersReview
      32. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancerReview
      33. Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancerReview
      34. Very early discharge versus early discharge versus non-early discharge in children with cancer and febrile neutropeniaReview
    3. Protocols
      1. Anti-GD2 antibody-containing immunotherapy post-consolidation therapy for people with high-risk neuroblastoma treated with autologous hematopoietic stem cell transplantationProtocol
      2. Breast cancer in female survivors of childhood, adolescent or young adult cancer after radiotherapy involving the chest for their primary malignancyProtocol
      3. Chemotherapy for treating high-grade osteosarcoma in children and young adultsProtocol
      4. Chemotherapy-related late adverse effects on ovarian function in female survivors of childhood cancer and cancer in the reproductive ageProtocol
      5. Clinical heart failure in children, adolescents and young adults treated with anthracyclines and/or irradiation involving the heart regionProtocol
      6. Empirical antibiotic therapy for febrile neutropenia in pediatric cancer patientsProtocol
      7. Fluorine-18-fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung and lymph node metastases in rhabdomyosarcomaProtocolDiagnostic
      8. Fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG-PET/CT) for detecting metastases of Ewing sarcomaProtocolDiagnostic
      9. High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents and young adults with first recurrence of Ewing sarcomaProtocol
      10. High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents and young adults with metastatic Ewing sarcomaProtocol
      11. Iodine-131-meta-iodobenzylguanidine therapy for patients with high-risk neuroblastomaProtocol
      12. Limb salvage for treating pathological fracture at diagnosis in children and adolescents with localized high grade osteosarcomaProtocol
      13. Radiotherapy for localised Ewing’s sarcoma in childrenProtocolWithdrawn
      14. Stem cell transplantation for high risk acute lymphoblastic leukaemia in paediatric patients in first remissionProtocolWithdrawn
      15. Temozolomide for children and adolescents with diffuse intrinsic pontine gliomaProtocolWithdrawn
  8. Cochrane Colorectal Cancer Group
  9. Cochrane Common Mental Disorders Group
  10. Cochrane Consumers and Communication Group
  11. Cochrane Cystic Fibrosis and Genetic Disorders Group
  12. Cochrane Dementia and Cognitive Improvement Group
  13. Cochrane Developmental, Psychosocial and Learning Problems Group
  14. Cochrane Drugs and Alcohol Group
  15. Cochrane Effective Practice and Organisation of Care Group
  16. Cochrane ENT Group
  17. Cochrane Epilepsy Group
  18. Cochrane Eyes and Vision Group
  19. Cochrane Fertility Regulation Group
  20. Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group
  21. Cochrane Gynaecology and Fertility Group
  22. Cochrane Haematological Malignancies Group
  23. Cochrane Heart Group
  24. Cochrane Hepato-Biliary Group
  25. Cochrane HIV/AIDS Group
  26. Cochrane Hypertension Group
  27. Cochrane IBD Group
  28. Cochrane Incontinence Group
  29. Cochrane Infectious Diseases Group
  30. Cochrane Injuries Group
  31. Cochrane Kidney and Transplant Group
  32. Cochrane Lung Cancer Group
  33. Cochrane Metabolic and Endocrine Disorders Group
  34. Cochrane Methodology Review Group
  35. Cochrane Movement Disorders Group
  36. Cochrane Multiple Sclerosis and Rare Diseases of the CNS Group
  37. Cochrane Musculoskeletal Group
  38. Cochrane Neonatal Group
  39. Cochrane Neuromuscular Group
  40. Cochrane Oral Health Group
  41. Cochrane Pain, Palliative and Supportive Care Group
  42. Cochrane Pregnancy and Childbirth Group
  43. Cochrane Public Health Group
  44. Cochrane Schizophrenia Group
  45. Cochrane Skin Group
  46. Cochrane STI Group
  47. Cochrane Stroke Group
  48. Cochrane Tobacco Addiction Group
  49. Cochrane Upper GI and Pancreatic Diseases Group
  50. Cochrane Urology Group
  51. Cochrane Vascular Group
  52. Cochrane Work Group
  53. Cochrane Wounds Group

SEARCH